Navigation Links
PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
Date:3/16/2009

BOSTON, March 16 /PRNewswire/ -- PAREXEL experts will address the benefits of rigorous early phase clinical development at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), to be held at the Gaylord National Resort in National Harbor, Maryland from March 18 - 21, 2009. The focus of PAREXEL's presence at the ASCPT meeting will be to help biopharmaceutical companies understand best practice approaches for identifying and selecting the most promising new compounds earlier.

During the meeting, Klaus Franke, M.D., Clinical Research Physician, Early Phase, PAREXEL will present the poster "A Study to Validate a Capsaicin Model of Experimental Pain in Healthy Human Volunteers," co-authored with PAREXEL colleagues Matthias Grossmann, M.D., Ph.D., Vice President, Early Phase Consulting Services; Edward Neuhoff, Neurophysiologist; and Dawie Wessels, Senior Director and Early Phase Unit Head. Dr. Franke will address the use of pain modeling in early development and advantages of combining traditional pharmacodynamic methods with relevant neuroscience biomarkers to achieve the goal of alleviating pain and related symptoms. Dr. Franke will discuss how this approach to enhance exploration of safety and efficacy and pharmacokinetic analysis can be applied to a broad range of psychiatry, neuropsychopharmacology, neuroimaging, and neurophysiology clinical studies to provide greater information about Central Nervous System (CNS) treatments. The presentation will be given during Poster Session II, starting at 8:00 a.m. on Friday, March 20.

PAREXEL Early Phase experts will be available at Booth 111 in the exhibit hall to discuss how the Company's fully integrated First in Man through Proof of Concept services can help biopharmaceutical companies generate better and faster go/no go decisions about their compounds and return solid, reproducible outcomes to succeed in later-phase trials. PA
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
2. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
3. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
4. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
5. PAREXEL Receives Best CRO Award from Scrip
6. PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies
7. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
8. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
9. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
10. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
11. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/--BiotechfirmReplikinsLtd.,whichhasanalyzedtheH1...ediction,outbreak,andprogressofthecurrentH1N1pande...rus.ThenewdatashowsthatthelethalityoftheH1N1("Swin...ngthevirus,scurrentoutbreakinthespringof2009torest...1virus,infectivitycount,however,remainsincreased. ...
(Date:11/25/2009)...re-Asia/--SinovacBiotechLtd.(SVA),aleadingdevelop...ed,ajointventure(JV)agreementtoestablishSinovac(Da...JVwillresearch,develop,produce,andcommercializehum...ndexperienceindevelopingandcommercializingworld-cl...s,manufacturingfacilitiesand,establishedoperatingi...
(Date:11/24/2009)...re-FirstCall/--IES(Nasdaq: IESC ),aleadingnational...vicesforthecommercial,industrialandresidentialmark...sbeenawardedacontractfromManhattanTorconJVtoinstal...-4)replacementfacilityattheU.S.ArmyMedicalResearch...ckinFrederick,Md. ,, ThenewUSAMRIIDreplacementf...
(Date:11/24/2009)...rio,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesC...eeds,adivisionofThompsonsLimitedofBlenheim,Ontario...ciences,currentseedsbusinessasthecompanyanticipate...groSciencesHerbicideTolerantTraitTechnologyincorni...re. ,, "Thisacquisitionbringstogethertwostrongp...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...matrix, Inc. today,announced that on April 22, 200...al Ben Franklin Emerging Business Awards, known as...ent Team category, competing with a,strong group o...a region.,BioNanomatrix chief executive officer Dr...f of the company., The Bennies, co-founded in 199...
...rWatch.biz announces the,availability of MarketSta...ets today within the biotechnology and diagnostic ... the aforementioned equities and the,opportunity f... on the,subject and sector., Investors can view S...w.SectorWatch.biz -- a division of financial news...
...roduct to 32,000+ healthcare providers, PRINCETON...n Board: DSCI), a provider of advanced wound care,... multi-year supply,agreement with one of the natio...ts Supply Chain Systems, a MedAssets company (Nasd...ve date of June 1, 2008, will help to,introduce ME...
Other Biology Technology:BioNanomatrix Named 'Best Management Team' at the 2008 Ben Franklin Emerging Business Awards 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 2Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 4
(Date:11/23/2009)... The time of day matters to forest trees dealing w...a research team led by Professor Malcolm Campbell,...l for research and colleagues in the department of.... , Capitalizing on their previous work to dec...am examined how poplar trees use their 45,000 gene...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
(Date:11/23/2009)... provides "incontrovertible evidence" that the vol...tra about 73,000 years ago deforested much of cent...searchers report. , The volcano ejected an estim...re, leaving a crater (now the world,s largest volc...meters wide. Ash from the event has been found in ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Operation Rescue 3A Wesley Medical Center Promises To Keep Carhart Abortions Out 54579 1Operation Rescue 3A Wesley Medical Center Promises To Keep Carhart Abortions Out 54579 2ULURU Inc Reports Second Quarter 2009 Financial Results 54576 1ULURU Inc Reports Second Quarter 2009 Financial Results 54576 2ULURU Inc Reports Second Quarter 2009 Financial Results 54576 3ULURU Inc Reports Second Quarter 2009 Financial Results 54576 4ULURU Inc Reports Second Quarter 2009 Financial Results 54576 5ULURU Inc Reports Second Quarter 2009 Financial Results 54576 6ULURU Inc Reports Second Quarter 2009 Financial Results 54576 7Senetek PLC Reports Second Quarter 2009 Financial Results 54573 1Senetek PLC Reports Second Quarter 2009 Financial Results 54573 2Senetek PLC Reports Second Quarter 2009 Financial Results 54573 3Senetek PLC Reports Second Quarter 2009 Financial Results 54573 4Senetek PLC Reports Second Quarter 2009 Financial Results 54573 5Senetek PLC Reports Second Quarter 2009 Financial Results 54573 6
...nd and ocean carbon sinks have on rising carbon em...ended the international Copenhagen Climate Change ...orbing carbon dioxide (CO 2 ) from the atmosphere ...h rapidly rising emissions," says CSIRO scientist ... Raupach. , "While these natural CO 2 sinks are ...
...e studying some common soil bacteria that "inhale"...m. , The bacteria might one day be used to clean ...production decades ago. , Using a unique combinat...ersity and their colleagues were able to glimpse h... metal to chemically extract oxygen. , The study,...
...ral therapy) has emerged as an extremely effective...tectable; however, HAART can never truly eradicate...ells. But, a chemical called suberoylanilide hydro... drug, has now been shown to ,turn on, latent HIV,... hidden virus that HAART misses. , Matija Peterl...
Other Biology News:Carbon sinks losing the battle with rising emissions 2Microscope reveals how bacteria 'breathe' toxic metals 2Microscope reveals how bacteria 'breathe' toxic metals 3
...ters are stored within neurons in vesicles called ...e synaptic bouton. Synaptosomes may be centrifuge...malites in neurotransmitter release have been prop...f release may be studied in isolated synaptosome p...
... Non-Radioactive Translation Detection Systems all...ed in vitro. Using these systems, biotinylated lys...s during translation, eliminating the need for lab...mino acids. This biotinylated lysine is added to t...
...ybridization chambers with forced convection Temp... / 212 F Patented APT.line preheating chamber ass...s DS controller Timer 0 to 24 h Digital tempera...ee Independent adjustable temperature safety devi...
...value of your microarray data using Asuragens bioi...d from consultation to extensive data analysis usi...ise in combination with the Gene Expression Profil...s., ,Normalization and basic statistical analy...
Biology Products: